Search

Atibuclimab

Atibuclimab (IC14) is a chimeric CD14 antibody investigated for the treatment of patients with severe sepsis.

CRx-139

It is a dissociated steroid designed to enhance the immuno-modulatory activity of a low-dose glucocorticoid steroid without a comparable increase in steroid-related side effects.

EGS21

It is a potential therapeutic for treating immune mediated disorders.

FINLAY-FR-1

It is currently being tested in the clinical trial RPCEC00000332 (Phase I / II, randomized, controlled, adaptive, double-blind and multicenter study to evaluate the safety, reactogenicity and immunogenicity

Cobamamide

It is therefore important to treat vitamin B12 deficiency with a combination of MeCbl and AdCbl or hydroxocobalamin or cobalamin [L2054].

Allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen

[L35505] It was developed as an alternative to autografting - the process by which a patient's own skin is harvested and grafted onto the burn site - which has the disadvantage of creating a new wound

DG041

It block the formation of blood clots mediated through inflammation in atherosclerotic plaques but without increasing bleeding risk.

GS-441524

[L13775] _In vitro_ studies of GS-441524 have determined it has a higher EC₅₀ than remdesivir against a number of viruses, meaning GS-441524 is less potent.

Licofelone

It is currently under evaluation as a treatment for osteoarthritis (OA), the most common form of arthritis.

Sufugolix